新型「切除与分析」策略:人工智能用于T2期结直肠癌淋巴结转移预测
本研究纳入2001至2016年接受手术切除的511例连续T2期结直肠癌患者,用411例(2001-2014年)训练基于随机森林的人工智能工具,100例(2014-2016年)验证其预测淋巴结转移的性能。验证队列中人工智能算法AUC为.93,灵敏度96%(95%CI 90%-99%),特异度88%(95%CI 80%-94%),64%的患者可避免手术,而1.6%的淋巴结转移患者会失去手术机会。作者认为该人工智能预测模型有潜力以很小风险减少T2期结直肠癌患者的不必要手术。
要点
- 人工智能模型纳入8项临床病理变量预测T2期结直肠癌淋巴结转移。
- 验证队列AUC为.93,灵敏度96%(95%CI 90%-99%),特异度88%(95%CI 80%-94%)。
- 作者认为该模型有潜力以很小风险减少不必要手术。
核心结论
- 作者认为所提出的人工智能预测模型有潜力以很小风险减少T2期结直肠癌患者的不必要手术。
研究设计与样本
- 纳入2001至2016年接受手术切除的511例连续T2期结直肠癌患者,411例(2001-2014年)作为训练集,100例(2014-2016年)作为验证集。
- 人工智能工具为基于随机森林的预测模型,纳入8项临床病理变量:患者年龄和性别、肿瘤大小和位置、淋巴管侵犯、血管侵犯、组织学分化、血清癌胚抗原水平。
主要发现
- 训练集淋巴结转移率为26%(106/411),验证集为28%(28/100)。
- 验证队列中人工智能算法的AUC为.93。
- 灵敏度为96%(95%CI 90%-99%),特异度为88%(95%CI 80%-94%)。
- 在此情况下,64%的患者可避免手术,而1.6%的淋巴结转移患者会失去手术机会。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Because of a lack of reliable preoperative prediction of lymph node involvement in early-stage T2 colorectal cancer (CRC), surgical resection is the current standard treatment. This leads to overtreatment because only 25% of T2 CRC patients turn out to have lymph node metastasis (LNM). We assessed a novel artificial intelligence (AI) system to predict LNM in T2 CRC to ascertain patients who can be safely treated with less-invasive endoscopic resection such as endoscopic full-thickness resection and do not need surgery. METHODS: We included 511 consecutive patients who had surgical resection with T2 CRC from 2001 to 2016; 411 patients (2001-2014) were used as a training set for the random forest-based AI prediction tool, and 100 patients (2014-2016) were used to validate the AI tool performance. The AI algorithm included 8 clinicopathologic variables (patient age and sex, tumor size and location, lymphatic invasion, vascular invasion, histologic differentiation, and serum carcinoembryonic antigen level) and predicted the likelihood of LNM by receiver-operating characteristics using area under the curve (AUC) estimates. RESULTS: Rates of LNM in the training and validation datasets were 26% (106/411) and 28% (28/100), respectively. The AUC of the AI algorithm for the validation cohort was .93. With 96% sensitivity (95% confidence interval, 90%-99%), specificity was 88% (95% confidence interval, 80%-94%). In this case, 64% of patients could avoid surgery, whereas 1.6% of patients with LNM would lose a chance to receive surgery. CONCLUSIONS: Our proposed AI prediction model has a potential to reduce unnecessary surgery for patients with T2 CRC with very little risk. (Clinical trial registration number: UMIN 000038257.).
引用
- Ichimasa K, Nakahara K, Kudo SE, et al. Novel "resect and analysis" approach for T2 colorectal cancer with use of artificial intelligence. Gastrointest Endosc. 2022. PMID: 35500659. doi:10.1016/j.gie.2022.04.1305
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。